ZYME
Get informed when a big investor buys or sells
+ FollowOvervalued by 175.1% based on the discounted cash flow analysis.
| Market cap | $1.73 Billion |
|---|---|
| Enterprise Value | $-145,193,069,311.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.08 |
| Beta | 1.13 |
| Outstanding Shares | 72,993,000 |
| P/E Ratio | -11.65 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.02 |
| Enterprise Value to Revenue | -57730.84 |
| Enterprise Value to EBIT | 1.3 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.22 |
| Debt to Equity | 0.4 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 12.72% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 12.36%▼ 80.93% |
|---|---|
| Total Invested | $240.52M▼ 86.33% |
| Investors Holding | 66▼ 155.00% |
No data